Patent ID: 7994200

Claim:
Cycloalkane-substituted pyrazoline compounds of general formula I, wherein Z is selected from C 1-4 -Alkyl, substituted or unsubstituted, branched or linear, saturated or unsaturated; X and Y independently represent phenyl, thienyl, naphtyl or pyridyl which groups may be substituted with 1, 2 or 3 substituents W, which can be the same or different, selected from the group branched or linear C 1-3 -alkyl or branched or linear C 1-3 -alkoxy, phenyl, hydroxy, chloro, bromo, fluoro, iodo, SH, trifluoromethyl, CHF 2 , CH 2 F, OCHF 2 , trifluoromethylthio, trifluoromethoxy, methylsulfonyl, carboxyl, trifluoromethylsulfonyl, cyano, carbamoyl, sulfamoyl and acetyl; O—P, with P denominating a prodrug group consisting of substituted or unsubstituted, branched or linear, saturated or unsaturated C 8-20 -alkyl or C(O)—C 1-20 -alkyl; substituted or unsubstituted aryl, alkyl-aryl, heterocyclyl or alkyl-heterocyclyl; substituted or unsubstituted C(O)-aryl, C(O)-alkyl-aryl, C(O)-heterocyclyl or C(O)-alkyl-heterocyclyl; R 8 representing Cycloalkyl—especially a C 7-8 -Cycloalkyl—unsubstituted or at least monosubstituted with 1, 2 or 3 substituents S′, which can be the same or different, selected from the group: H, F, Cl, Br, I, OH, SH, C 1-4 alkyl, C 1-4 alkoxy, CF 3 , CHF 2 , CH 2 F, OCF 3 , a keto-group, NO 2 or NH 2 ; n being 0 or 1 optionally in the form of its racemate, pure stereoisomers, especially enantiomers or diastereomers or in the form of mixtures of stereoisomers, especially enantiomers or diastereomers, in any suitable ratio; in the form shown or in the form of an acid or base or in the form of a salt, especially a physiologically acceptable salt, or in the form of a corresponding N-oxide.